Any income generated by the REVO patents has been received by Eyetalk365, but Eyetalk365 has no reporting obligations to REVO shareholders. And REVO directors have refused to meet their reporting obligations.
As a result REVO shareholders know absolutely nothing about income received by, or from, Eyetalk365.
As you correctly point out:
There is no benefit to REVO shareholders because the REVO directors are keeping the money for their own benefit.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.